| human | Q5 |
| P496 | ORCID iD | 0000-0003-4814-2158 |
| P1153 | Scopus author ID | 55621882500 |
| P734 | family name | Huppertz | Q56538725 |
| Huppertz | Q56538725 | ||
| Huppertz | Q56538725 | ||
| P735 | given name | Berthold | Q827835 |
| Berthold | Q827835 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q56772483 | Q56772483 |
| Q61865474 | 3-dimensional colour power angiography for staging human placental development |
| Q33918875 | A comparative study of five physiological key parameters between four different human trophoblast-derived cell lines |
| Q61865464 | A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells |
| Q38222393 | A possible protective role of Nrf2 in preeclampsia |
| Q35806135 | A role for GPR55 in human placental venous endothelial cells |
| Q34442777 | A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia |
| Q38010711 | A variety of opportunities for immune interactions during trophoblast development and invasion. |
| Q38440245 | Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome |
| Q45183524 | Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro |
| Q61865456 | Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR |
| Q61865423 | Amnion-Derived Mesenchymal Stromal Cells Show Angiogenic Properties but Resist Differentiation into Mature Endothelial Cells |
| Q45416548 | Amnion-derived mesenchymal stromal cells show a mesenchymal-epithelial phenotype in culture |
| Q61865481 | An improved and rapid method to construct skin equivalents from human hair follicles and fibroblasts |
| Q38167581 | An integrative view on the physiology of human early placental villi |
| Q58564287 | An updated view on the origin and use of angiogenic biomarkers for preeclampsia |
| Q54161204 | Anti-adhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid. |
| Q36437226 | Apoptosis and its role in the trophoblast |
| Q35879137 | Apoptosis in the trophoblast--role of apoptosis in placental morphogenesis |
| Q61865483 | Apoptosis: Molecular Control of Placental Function—A Workshop Report |
| Q61865441 | Apoptotic death ligands and interleukins in the vitreous of diabetic patients |
| Q30558415 | Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer? |
| Q37698646 | Arterial endothelial cytokines guide extravillous trophoblast invasion towards spiral arteries; an in-vitro study with the trophoblast cell line ACH-3P and female non-uterine endothelial cells |
| Q61865496 | Author's reply to commentary by Hennig Stieve |
| Q61865431 | Barrier thickness matters |
| Q60793593 | Bi-potential Behaviour of Cytotrophoblasts in First Trimester Chorionic Villi |
| Q37639844 | Biobanking of different body fluids within the frame of IVF-a standard operating procedure to improve reproductive biology research. |
| Q41576045 | CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia |
| Q39792490 | Caspases rather than calpains mediate remodelling of the fodrin skeleton during human placental trophoblast fusion |
| Q38371951 | Challenges and Driving Forces for Business Plans in Biobanking |
| Q39317334 | Characterization of fetal cells from the maternal circulation by microarray gene expression analysis--could the extravillous trophoblasts be a target for future cell-based non-invasive prenatal diagnosis? |
| Q57108002 | Circulating fetal DNA in maternal plasma is increased in pregnancies at high altitude and is further enhanced by preeclampsia |
| Q34319764 | Complex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placenta. |
| Q61865466 | Concerted Upregulation of CLP36 and Smooth Muscle Actin Protein Expression in Human Endometrium during Decidualization |
| Q48125639 | Correction to: Expression of matrix metalloproteinase 12 is highly specific for non-proliferating invasive trophoblasts in the first trimester and temporally regulated by oxygen-dependent mechanisms including HIF-1A. |
| Q51610864 | Cryogenic and low temperature preservation of human placental villous explants - a new way to explore drugs in pregnancy disorders. |
| Q36528411 | Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia |
| Q40909133 | Cytogenetic and DNA-fingerprint characterization of choriocarcinoma cell lines and a trophoblast/choriocarcinoma cell hybrid. |
| Q61865451 | Cytokeratin Antibodies as Differential Markers of Trophoblast and Fetomaternal Syncytial Plaques in the Sheep Placentome |
| Q61865442 | Cytotoxic Effect of Advanced Glycation end Products |
| Q38373823 | DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. |
| Q34552108 | Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro |
| Q61850396 | Development of early non-invasive markers and means for the diagnosis and progression monitoring of preeclampsia and tailoring putative therapies (project pregenesys 037244) |
| Q34032277 | Development of the placental villous tree and its consequences for fetal growth |
| Q36030154 | Developmental biology of the placenta and the origins of placental insufficiency |
| Q40804586 | Differences in d-chiro-inositol-phosphoglycan expression between first and third trimester human placenta |
| Q39737754 | Differential expression of VE-cadherin and VEGFR2 in placental syncytiotrophoblast during preeclampsia - New perspectives to explain the pathophysiology |
| Q46737535 | Distribution of decidual natural killer cells and macrophages in the neighbourhood of the trophoblast invasion front: a quantitative evaluation |
| Q46534463 | Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker |
| Q61865458 | Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction |
| Q53302463 | Does 2D-Histologic identification of villous types of human placentas at birth enable sensitive and reliable interpretation of 3D structure? |
| Q61865452 | Effect of high oxygen on placental function in short-term explant cultures |
| Q43952086 | Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants |
| Q46588322 | Effects of circulating and local uteroplacental angiotensin II in rat pregnancy |
| Q53509352 | Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. |
| Q45783688 | Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents |
| Q39721970 | Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells |
| Q35794508 | Endogenous retroviral syncytin: compilation of experimental research on syncytin and its possible role in normal and disturbed human placentogenesis |
| Q42650529 | Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models |
| Q61865430 | Endothelin-1 Stimulates Proliferation of First-Trimester Trophoblasts via the A- and B-Type Receptor and Invasion via the B-Type Receptor |
| Q35079406 | Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia |
| Q61865498 | Evidence for a cGMP gated cation channel in photoreceptor cell membranes ofSepia officinalis |
| Q36480686 | Evidence from the very beginning: endoglandular trophoblasts penetrate and replace uterine glands in situ and in vitro |
| Q51067523 | Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface. |
| Q61865485 | Expression of a Cytokeratin 18 Neo-epitope is a Specific Marker for Trophoblast Apoptosis in Human Placenta |
| Q47679507 | Expression of matrix metalloproteinase 12 is highly specific for non-proliferating invasive trophoblasts in the first trimester and temporally regulated by oxygen-dependent mechanisms including HIF-1A. |
| Q33992037 | Expression of serum amyloid A4 in human trophoblast-like choriocarcinoma cell lines and human first trimester/term trophoblast cells |
| Q34512969 | Expression of the actin stress fiber-associated protein CLP36 in the human placenta |
| Q61865494 | Extracellular matrix components of the placental extravillous trophoblast: immunocytochemistry and ultrastructural distribution |
| Q42526396 | Extracellular matrix components of the placental extravillous trophoblast: immunocytochemistry and ultrastructural distribution |
| Q61865477 | Extracellular pH modulates the secretion of fibronectin isoforms by human trophoblast |
| Q61865468 | Extravillous trophoblast apoptosis – A workshop report |
| Q39256200 | Extravillous trophoblasts invade more than uterine arteries: evidence for the invasion of uterine veins |
| Q61865443 | Factors Involved in Regulating Trophoblast Fusion: Potential Role in the Development of Preeclampsia |
| Q36182206 | Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? |
| Q45079728 | Fetal growth restriction: a workshop report. |
| Q39598613 | Fibulin-5 expression in the human placenta |
| Q38020351 | First trimester serum markers to predict preeclampsia |
| Q51735260 | Fusion of villous trophoblast can be visualized by localizing active caspase 8. |
| Q51033417 | GDM alters paracrine regulation of feto-placental angiogenesis via the trophoblast. |
| Q91519348 | Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy |
| Q37710703 | Governing the invasive trophoblast: current aspects on intra- and extracellular regulation. |
| Q37593267 | HO-1 inhibits preadipocyte proliferation and differentiation at the onset of obesity via ROS dependent activation of Akt2. |
| Q28213788 | Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure |
| Q51566031 | Hofbauer cells of M2a, M2b and M2c polarization may regulate feto-placental angiogenesis. |
| Q36159671 | Human placental explants in culture: approaches and assessments. |
| Q61865425 | Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome |
| Q40786267 | Human trophoblast contains an intracellular protein reactive with an antibody against CD133--a novel marker for trophoblast. |
| Q61865418 | Human trophoblast invasion: new and unexpected routes and functions |
| Q44302005 | Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation |
| Q48310816 | IFPA Award in Placentology Lecture: Biology of the placental syncytiotrophoblast--myths and facts |
| Q37517714 | IFPA Meeting 2011 workshop report III: Placental immunology; epigenetic and microRNA-dependent gene regulation; comparative placentation; trophoblast differentiation; stem cells |
| Q28754740 | IFPA meeting 2008 workshops report |
| Q97525336 | IJMS Special Issue "Molecular and Cellular Mechanisms of Preeclampsia"-Editorial |
| Q61865492 | Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta |
| Q46759669 | Impact of constant storage temperatures and multiple warming cycles on the quality of stored red blood cells |
| Q38373184 | Implantation and extravillous trophoblast invasion: From rare archival specimens to modern biobanking |
| Q61865426 | Implantationsstörungen, Präeklampsie und intrauterine Wachstumsrestriktion |
| Q34992918 | In-vitro effects of the antimicrobial peptide Ala8,13,18-magainin II amide on isolated human first trimester villous trophoblast cells |
| Q51008525 | Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia. |
| Q33529066 | Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface |
| Q61865420 | Innovative ways for information transfer in biobanking |
| Q61865478 | Invasive depth of extravillous trophoblast correlates with cellular phenotype: a comparison of intra- and extrauterine implantation sites |
| Q38085585 | Keratins in the human trophoblast |
| Q36857909 | Letter from the guest editors: Cell adhesion, migration, and fusion in placenta |
| Q61865449 | Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia |
| Q61865487 | Low-dose-rate ionizing irradiation for inhibition of secondary cataract formation |
| Q41523614 | Magnetomitotransfer: An efficient way for direct mitochondria transfer into cultured human cells |
| Q38298434 | Maternal-fetal interactions, predictive markers for preeclampsia, and programming |
| Q46319653 | Maternal-placental interactions and fetal programming |
| Q42513878 | Matrix metalloproteinases-2, -3 and -9 in human term placenta |
| Q51736242 | Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo. |
| Q37686780 | Metalloprotease dependent release of placenta derived fractalkine |
| Q61865459 | Minimal Alteration in the Ratio of Circulatory Fetal DNA to Fetal Corticotropin-Releasing Hormone mRNA Level in Preeclampsia |
| Q42505498 | Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice |
| Q48134839 | N-cadherin knockdown leads to disruption of trophoblastic and endothelial cell interaction in a 3D cell culture model - New insights in trophoblast invasion failure |
| Q61865499 | Na+−Ca2+,K+ exchange in bovine retinal rod outer segments: quantitative characterization of normal and reversed mode |
| Q36371864 | New insights into the biology of preeclampsia |
| Q30321228 | Nucleic acid sequence of feline preprorelaxin and its localization within the feline placenta. |
| Q39322724 | OS066. Intrauterine CYP2J2 expression and circulatingepoxyeicosatrienoic acid levels in preeclampsia |
| Q61865421 | Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction |
| Q37392329 | Oxygen as modulator of trophoblast invasion |
| Q39447724 | Oxygen modulates the response of first-trimester trophoblasts to hyperglycemia |
| Q40805143 | PP015. Differential expression of Nrf2 and VEGF in human placental beds from normal and pregnancies complicated with preeclampsia and IUGR. |
| Q40804191 | PP019. A new player in preeclampsia: The NF-E2-related factor 2 (NRF2). |
| Q40804138 | PP033. Oxidized LDL particles in the placenta of intrauterine growth restriction (IUGR) subgroups |
| Q59438252 | Pathogenesis of Intrauterine Growth Restriction (IUGR)—Conclusions Derived from a European Union Biomed 2 Concerted Action Project ‘Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies’—A Workshop Report |
| Q42373442 | Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function |
| Q55692173 | Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits. |
| Q38943433 | Phospholipid scramblase 1 (PLSCR1) in villous trophoblast of the human placenta |
| Q112276274 | Physical Activity and Sedentary Time in Pregnancy: An Exploratory Study on Oxidative Stress Markers in the Placenta of Women with Obesity |
| Q39698792 | Pigment epithelium-derived factor (PEDF): a novel trophoblast-derived factor limiting feto-placental angiogenesis in late pregnancy. |
| Q43581085 | Pixelwise quantification of placental perfusion visualized by 3D power Doppler sonography |
| Q37315590 | Placenta trophoblast fusion |
| Q61865433 | Placenta-bound and Body Fluid PP13 and its mRNA in Normal Pregnancy Compared to Preeclampsia, HELLP and Preterm Delivery |
| Q61865454 | Placental Angiogenesis, Maternal and Fetal Vessels – A Workshop Report |
| Q38969936 | Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling |
| Q37831658 | Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia |
| Q61865429 | Placental expression of d-chiro-inositol phosphoglycans in preeclampsia |
| Q50947119 | Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies. |
| Q35802535 | Placental fractalkine is up-regulated in severe early-onset preeclampsia |
| Q35804672 | Placental fractalkine mediates adhesion of THP-1 monocytes to villous trophoblast |
| Q61865436 | Placental markers of folate-related metabolism in preeclampsia |
| Q34751358 | Placental mesenchymal stromal cells derived from blood vessels or avascular tissues: what is the better choice to support endothelial cell function? |
| Q36423375 | Placental morphology: from molecule to mother -- a dedication to Peter Kaufmann -- a review. |
| Q37079631 | Placental origins of preeclampsia: challenging the current hypothesis |
| Q46328652 | Placental pathology in pregnancy complications |
| Q64112776 | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
| Q50992588 | Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways. |
| Q34328411 | Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia |
| Q61865475 | Pre-eclampsia and Maternal Anaemia Display Reduced Apoptosis and Opposite Invasive Phenotypes of Extravillous Trophoblast |
| Q47362589 | Pre-eclampsia as a 'three stage problem'--a workshop report. |
| Q50879778 | Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age. |
| Q36968505 | Prediction of preeclampsia - a workshop report |
| Q36295102 | Preeclampsia - Aetiology, Current Diagnostics and Clinical Management, New Therapy Options and Future Perspectives |
| Q61865455 | Preeclampsia: Placental Origins, New Predictors and New Therapeutic Strategies |
| Q61865448 | Preface |
| Q37823984 | Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? |
| Q43503964 | Proliferative responses in the placenta after endotoxin exposure in preterm fetal sheep |
| Q38374809 | Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking |
| Q36373205 | Regulation of proliferation and apoptosis during development of the preimplantation embryo and the placenta |
| Q33981931 | Retracted: The Role of the Carbohydrate Recognition Domain of Placental Protein 13 (PP13) in Pregnancy Evaluated with Recombinant PP13 and the DelT221 PP13 Variant |
| Q45926626 | Role of a fetal defence mechanism against oxidative stress in the aetiology of preeclampsia. |
| Q61865462 | Sequential Steps During Vasculogenesis and Angiogenesis in the Very Early Human Placenta |
| Q47626896 | Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. |
| Q38070020 | Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies |
| Q51543784 | Soluble factors released by placental villous tissue: Interleukin-1 is a potential mediator of endothelial dysfunction. |
| Q61865463 | Spatial and Temporal Distribution of Tie-1 and Tie-2 During Very Early Development of the Human Placenta |
| Q38384177 | Sustainability in Biobanking: Model of Biobank Graz |
| Q61865472 | Syncytial fusion of human trophoblast depends on caspase 8 |
| Q42487293 | TNF-α alters the inflammatory secretion profile of human first trimester placenta |
| Q35055837 | The 'reference trap' revisited: examples of the dangers in using ratios to describe fetoplacental angiogenesis and trophoblast turnover. |
| Q61865490 | The Distribution of Macrophages in Spiral Arteries of the Placental Bed in Pre-eclampsia Differs from that in Healthy Patients |
| Q35909383 | The Salivary Scavenger and Agglutinin (SALSA) in Healthy and Complicated Pregnancy |
| Q37255637 | The anatomy of the normal placenta |
| Q50690523 | The art of identification of extravillous trophoblast. |
| Q39669334 | The choriocarcinoma cell line BeWo: syncytial fusion and expression of syncytium-specific proteins |
| Q39385098 | The effects of Nrf2 deletion on placental morphology and exchange capacity in the mouse |
| Q36875734 | The feto-maternal interface: setting the stage for potential immune interactions |
| Q41331763 | The fibrinoids of the human placenta: origin, composition and functional relevance. |
| Q33311390 | The first trimester human trophoblast cell line ACH-3P: a novel tool to study autocrine/paracrine regulatory loops of human trophoblast subpopulations--TNF-alpha stimulates MMP15 expression |
| Q42484210 | The human placenta is encircled by a ring of smooth muscle cells. |
| Q37665638 | The paradox of caspase 8 in human villous trophoblast fusion |
| Q38150966 | The placental exposome: placental determinants of fetal adiposity and postnatal body composition |
| Q37402210 | The trophoblast plug during early pregnancy: a deeper insight |
| Q46525869 | The trophoblast survival capacity in preeclampsia. |
| Q33786230 | The vitamin E-binding protein afamin increases in maternal serum during pregnancy |
| Q92445843 | Traditional and New Routes of Trophoblast Invasion and Their Implications for Pregnancy Diseases |
| Q61865489 | Trophoblast Apoptosis and Placental Development—A Workshop Report |
| Q60221776 | Trophoblast and the Endometrium—A Workshop Report |
| Q61865438 | Trophoblast differentiation, fetal growth restriction and preeclampsia |
| Q37856923 | Trophoblast fusion |
| Q36404611 | Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion |
| Q38112918 | Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions |
| Q52613197 | Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. |
| Q61865480 | Trophoblast turnover in health and disease |
| Q39962149 | Trophoblastic invasion in vitro and in vivo: similarities and differences |
| Q56981910 | Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response |
| Q36376468 | Ultrasound detection of placental insufficiency in women with 'unexplained' abnormal maternal serum screening results. |
| Q61865476 | Unterschiede in der Trophoblastinvasion bei der Tubar- und Intrauteringravidität |
| Q61865424 | Untersuchungen des maternalen und fetalen Serumlipidprofils und des oxidierten ‚Low Density‘ Lipoproteins im plazentaren Gewebe bei Präeklampsie und normotensiven Schwangerschaften |
| Q36279890 | Vascular biology in implantation and placentation. |
| Q36851553 | Vasculogenesis and angiogenesis in the early human placenta |
| Q37501370 | Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation |
| Q61865471 | Vermehrte Expression der induzierbaren NO-Synthase (iNOS) in Makrophagen des Plazentabettes bei schwerer Präeklampsie |
| Q61865493 | Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta |
| Q34068559 | Villous sprouting: fundamental mechanisms of human placental development. |
| Q57289775 | d-chiro-inositol phosphoglycan expression in human placenta at term in diabetes |
Search more.